Our findings suggest that elevated Slit2 levels in bone tissue may exert a protective effect against osteoporosis progression, providing valuable insights into the potential of Slit2 as a therapeutic target for osteoporosis. The gene discussed is SLIT2; the disease is osteoporosis.